Big Pharma Split Corp.

PRM

CA08934P1080

Mutual Funds

Market Closed - Toronto S.E. Other stock markets 11:47:24 17/05/2024 pm IST			5-day change	1st Jan Change
14.4 ^CAD	+0.70%		+2.42%	+4.73%

23/04	Big Pharma Split Corp. Declares April 2024 Distribution, Payable on May 9, 2024	CI
29/03	Big Pharma Split Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Big Pharma Split Corp. Announces October 2023 Distribution, Payable November 9, 2023

October 17, 2023 at 05:00 pm IST

Big Pharma Split Corp. declares the monthly cash distribution payable for Big Pharma Split Corp. of $0.1031 for each class A share (PRM:TSX) for the month ending October 31, 2023.

The distribution is payable November 9, 2023 to class A shareholders of record at the close of business October 31, 2023.

Latest news about Big Pharma Split Corp.

Big Pharma Split Corp. Declares April 2024 Distribution, Payable on May 9, 2024	23/04	CI
Big Pharma Split Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Big Pharma Split Corp. Declares March 2024 Distributions, Payable on April 9, 2024	21/03	CI
Big Pharma Split Corp. Declares February 2024 Distributions, Payable on March 8, 2024	22/02	CI
Harvest Portfolios Group Inc. Declares Big Pharma Split Corp. Class A Special Capital Gains Distribution, Payable on February 26, 2024	15/02	CI
Big Pharma Split Corp. Declares Monthly Cash Distribution for Each Class A Share for the Month Ending January 31, 2024, Payable February 9, 2024	24/01	CI
Big Pharma Split Corp. Declares Monthly Cash Distribution for Month Ending December 31, 2023, Payable on January 9, 2024	18/12	CI
Big Pharma Split Corp. Declares Monthly Cash Distribution for Month Ending November 30, 2023, Payable on December 8, 2023	17/11	CI
Big Pharma Split Corp. Announces October 2023 Distribution, Payable November 9, 2023	17/23/17	CI
Big Pharma Split Corp. Declares Monthly Cash Distribution Payable for Each Class A Share for the Month Ending September 30, 2023, Payable October 6, 2023	19/23/19	CI
Big Pharma Split Corp. Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
Big Pharma Split Corp. Declares Cash Distribution on Class A Share for the Month Ending August 31, 2023, Payable on September 8, 2023	18/23/18	CI
Big Pharma Split Corp. Declares Cash Distribution for the Month Ending July 31, 2023, Payable on August 9, 2023	19/23/19	CI
Big Pharma Split Corp. Declares the Monthly Cash Distribution of June 2023, Payable July 7, 2023	19/23/19	CI
Big Pharma Split Corp. Declares Distribution for the Month Ending May 31, 2023, Payable on June 9, 2023	18/23/18	CI
Big Pharma Split Corp. Declares Cash Distribution on A Shares for the Month Ending April 30, 2023, Payable on May 9, 2023	24/23/24	CI
Big Pharma Split Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
Big Pharma Split Corp. Declares Cash Distribution on A Shares for the Month Ending March 31, 2023, Payable on April 6, 2023	21/23/21	CI
Big Pharma Split Corp. Declares Cash Distribution for the Month Ending February 28, 2023, Payable March 9, 2023	22/23/22	CI
Big Pharma Split Corp. Declares Monthly Cash Distribution for the Month Ending January 31, 2023, Payable on February 9, 2023	20/23/20	CI
Big Pharma Split Corp Declares December 2022 Distribution, Payable 9 January , 2023	21/22/21	CI
Big Pharma Split Corp Declares November 2022 Distribution, Payable December 9, 2022	21/22/21	CI
Big Pharma Split Corp. Announces Board Changes	24/22/24	CI
Harvest Portfolios Group Inc. Declares Big Pharma Split Corp.'s Cash Distribution for the Month Ending October 2022, Payable on November 9, 2022	21/22/21	CI
Harvest Portfolios Group Inc. Declares Monthly Cash Distribution for the Month Ending September 30, 2022, Payable on October 7, 2022	21/22/21	CI

Big Pharma Split Corp. is a Canada-based investment fund. The Companyâs investment objectives for the Preferred shares are to provide their holders with fixed cumulative preferential quarterly cash distributions in the amount of $0.125 per Preferred share and to return the original issue price of $10.00 to holders on the maturity date. Its investment objectives for the Class A shares are to provide their holders with regular monthly non-cumulative cash distributions targeted to be $0.1031 per Class A share representing a yield on the issue price of the Class A shares of 8.25% per annum on the issue price of $15.00 per Class A share and to provide holders with the opportunity for growth in the net asset value per Class A share. It will invest in an initially equally weighted portfolio (the Portfolio) comprised of Equity Securities of ten issuers, selected by the portfolio manager from the investable universe. Its portfolio manager is Harvest Portfolios Group Inc.

Sector

Mutual Funds

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Mutual Funds

	1st Jan change	Capi.
BIG PHARMA SPLIT CORP.	+4.73%	12.22M
GUGGENHEIM ACTIVE ALLOCATION FUND	+1.77%	492M
CANADIAN BANC CORP.	+7.00%	241M
NORTH AMERICAN FINANCIAL 15 SPLIT CORP.	+37.19%	231M
DIVIDEND GROWTH SPLIT CORP.	+20.90%	196M
GLOBAL DIVIDEND GROWTH SPLIT CORP.	+12.53%	116M
IMMORENTE INVEST S.A.	+1.83%	84.58M
PREMIUM INCOME CORPORATION	-13.37%	52.14M

Other Mutual Funds